These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 15946658)

  • 1. A proteomic approach in the study of an animal model of Parkinson's disease.
    De Iuliis A; Grigoletto J; Recchia A; Giusti P; Arslan P
    Clin Chim Acta; 2005 Jul; 357(2):202-9. PubMed ID: 15946658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats.
    Liu CQ; Chen Z; Liu FX; Hu DN; Luo JH
    Neuropharmacology; 2007 Dec; 53(7):832-41. PubMed ID: 17919665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
    Aponso PM; Faull RL; Connor B
    Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma.
    Tezel G; Yang X; Cai J
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3177-87. PubMed ID: 16123417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration.
    Rite I; Argüelles S; Venero JL; García-Rodriguez S; Ayala A; Cano J; Machado A
    J Neurosci Res; 2007 Dec; 85(16):3607-18. PubMed ID: 17705290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of expression and protein interactions in a 6-hydroxydopamine-induced rat brain lesion model.
    Park B; Yang J; Yun N; Choe KM; Jin BK; Oh YJ
    Neurochem Int; 2010 Aug; 57(1):16-32. PubMed ID: 20403401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
    J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease.
    Shim JS; Kim HG; Ju MS; Choi JG; Jeong SY; Oh MS
    J Ethnopharmacol; 2009 Nov; 126(2):361-5. PubMed ID: 19703534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
    Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R
    Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
    Dabbeni-Sala F; Di Santo S ; Franceschini D; Skaper SD; Giusti P
    FASEB J; 2001 Jan; 15(1):164-170. PubMed ID: 11149904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of striatal proteins in the rat model of L-DOPA-induced dyskinesia.
    Valastro B; Dekundy A; Krogh M; Lundblad M; James P; Danysz W; Quack G; Cenci MA
    J Neurochem; 2007 Aug; 102(4):1395-409. PubMed ID: 17532790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
    Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential proteome of the striatum from hemiparkinsonian rats displays vivid structural remodeling processes.
    Lessner G; Schmitt O; Haas SJ; Mikkat S; Kreutzer M; Wree A; Glocker MO
    J Proteome Res; 2010 Sep; 9(9):4671-87. PubMed ID: 20666516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA receptors mediate an early up-regulation of brain-derived neurotrophic factor expression in substantia nigra in a rat model of presymptomatic Parkinson's disease.
    Bustos G; Abarca J; Bustos V; Riquelme E; Noriega V; Moya C; Campusano J
    J Neurosci Res; 2009 Aug; 87(10):2308-18. PubMed ID: 19326433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract.
    Van Camp N; Blockx I; Verhoye M; Casteels C; Coun F; Leemans A; Sijbers J; Baekelandt V; Van Laere K; Van der Linden A
    NMR Biomed; 2009 Aug; 22(7):697-706. PubMed ID: 19378292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease.
    Engler H; Doenlen R; Riether C; Engler A; Niemi MB; Besedovsky HO; del Rey A; Pacheco-López G; Feldon J; Schedlowski M
    Brain Behav Immun; 2009 May; 23(4):518-26. PubMed ID: 19486644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease.
    Forsback S; Niemi R; Marjamäki P; Eskola O; Bergman J; Grönroos T; Haaparanta M; Haapalinna A; Rinne J; Solin O
    Synapse; 2004 Feb; 51(2):119-27. PubMed ID: 14618679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of dopaminergic neurons by electroconvulsive shock in an animal model of Parkinson's disease.
    Anastasia A; de Erausquin GA; Wojnacki J; Mascó DH
    J Neurochem; 2007 Nov; 103(4):1542-52. PubMed ID: 17854351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.